Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02811718 · ClinicalTrials.gov registry record · NA
Resiliency Training for Patients With NF2 Via Videoconferencing With Skype
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT02811718: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02811718 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 45 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02811718, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The aim of this study is to determine, whether the 3RP is feasible, accepted and efficacious and durable when delivered via Skype to patients with neurofibromatosis type 2 (NF2) who are deaf or have severe hearing loss using Communication Access Realtime Translation (CART) and/or American Sign Language (ASL). This will be a substudy of the IRB-approved protocol #2013P002605. It is the same study except it is looking at a particular sub-population: patients with NF2 who are hard of hearing.
Interventions
- BEHAVIORAL Stress Management Group 1
- BEHAVIORAL Stress Management Group 2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-07 |
| Est. Completion | 2018-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02811718
The ClinicalTrials.gov registry entry for NCT02811718 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stress Management Group 1 is the first listed.
NCT02811718 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02811718 about?
NCT02811718 is a clinical study titled "Resiliency Training for Patients With NF2 Via Videoconferencing With Skype". The aim of this study is to determine, whether the 3RP is feasible, accepted and efficacious and durable when delivered via Skype to patients with neurofibromatosis type 2 (NF2) who are deaf or have severe hearing loss using Communication Access Realtime Translation (CART) and/or American Sign Langu...
What is the current status of trial NCT02811718?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2016-07. Estimated completion is 2018-07.
What interventions are being tested in trial NCT02811718?
The interventions under investigation include: Stress Management Group 1 (BEHAVIORAL), Stress Management Group 2 (BEHAVIORAL).
Who is sponsoring clinical trial NCT02811718?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.